Provided by Tiger Trade Technology Pte. Ltd.

CG Oncology Inc.

78.23
-1.5800-1.98%
Post-market: 78.230.00000.00%16:10 EDT
Volume:947.53K
Turnover:74.35M
Market Cap:6.93B
PE:-28.72
High:79.89
Open:79.44
Low:77.51
Close:79.81
52wk High:80.97
52wk Low:25.25
Shares:88.64M
Float Shares:64.73M
Volume Ratio:1.27
T/O Rate:1.46%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.7235
EPS(LYR):-2.0826
ROE:-26.41%
ROA:-17.67%
PB:6.74
PE(LYR):-37.56

Loading ...

Apr 28, 2025

Major Issues Report

Form 8-K - Current report
Mar 28, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 28, 2025

Major Issues Report

Form 8-K - Current report
Mar 24, 2025

Major Issues Report

Form 8-K - Current report
Mar 17, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 10, 2025

Major Issues Report

Form 8-K - Current report
Dec 11, 2024

Correspondence

Form CORRESP - Correspondence
Dec 11, 2024

Correspondence

Form CORRESP - Correspondence
Dec 11, 2024

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Dec 11, 2024

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Dec 06, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 05, 2024

Major Issues Report

Form 8-K - Current report
Nov 12, 2024

Major Issues Report

Form 8-K - Current report
Nov 12, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 29, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 29, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 29, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 29, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 08, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 08, 2024

Major Issues Report

Form 8-K - Current report